ASL-话题@MedSci

#ASL#

165篇内容 | 3062人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1519219, encodeId=8a151519219d7, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=J Cereb Blood Flow Metab：大脑中动脉狭窄没有症状？ASL告诉你侧支循环灌注的差异！, objectType=article, longId=108516, objectId=833b10851625, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=833b10851625, replyNumber=0, likeNumber=60, createdTime=2017-08-13, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=833b10851625, moduleTitle=J Cereb Blood Flow Metab：大脑中动脉狭窄没有症状？ASL告诉你侧支循环灌注的差异！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=833b10851625)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519218, encodeId=bdc6151921885, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=STROKE：玩转PET-MRI:在Moyamoya患者中，长时延迟ASL能够准确评估脑血流量, objectType=article, longId=107655, objectId=2ac710e655f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ac710e655f0, replyNumber=0, likeNumber=62, createdTime=2017-08-05, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ac710e655f0, moduleTitle=STROKE：玩转PET-MRI:在Moyamoya患者中，长时延迟ASL能够准确评估脑血流量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ac710e655f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519217, encodeId=73ff151921e6e, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=J Cereb Blood Flow Metab：预测急性脑卒中缺血再灌注后出血之利器——再灌注治疗后ASL脑血流高灌注表现与出血相关, objectType=article, longId=105208, objectId=fb391052087e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb391052087e, replyNumber=0, likeNumber=64, createdTime=2017-07-12, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb391052087e, moduleTitle=J Cereb Blood Flow Metab：预测急性脑卒中缺血再灌注后出血之利器——再灌注治疗后ASL脑血流高灌注表现与出血相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb391052087e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519216, encodeId=12211519216e2, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=EASL 2017：肝癌晚期应该怎么办？, objectType=article, longId=97266, objectId=2dcb9e2663a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dcb9e2663a, replyNumber=0, likeNumber=26, createdTime=2017-04-28, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dcb9e2663a, moduleTitle=EASL 2017：肝癌晚期应该怎么办？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dcb9e2663a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519215, encodeId=f8741519215c0, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=APASL分享EFFORT研究结果：替比夫定优化治疗降低耐药率至3.3%, objectType=article, longId=90338, objectId=76a59033872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76a59033872, replyNumber=0, likeNumber=73, createdTime=2017-03-03, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76a59033872, moduleTitle=APASL分享EFFORT研究结果：替比夫定优化治疗降低耐药率至3.3%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76a59033872)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519214, encodeId=4a321519214b2, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=热烈祝贺“2017第26届亚太肝脏研究学会年会APASL”圆满成功！, objectType=article, longId=89459, objectId=9ff489459e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ff489459e7, replyNumber=0, likeNumber=46, createdTime=2017-02-22, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ff489459e7, moduleTitle=热烈祝贺“2017第26届亚太肝脏研究学会年会APASL”圆满成功！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ff489459e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519213, encodeId=5282151921361, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=[APASL访谈]杨希忠教授：为了没有肝炎的未来, objectType=article, longId=89411, objectId=f4588941131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4588941131, replyNumber=0, likeNumber=0, createdTime=2017-02-22, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4588941131, moduleTitle=[APASL访谈]杨希忠教授：为了没有肝炎的未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4588941131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519212, encodeId=dbbc1519212cd, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=APASL 2017：第二十六届亚太肝病学会年会, objectType=article, longId=81770, objectId=305a81e70ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=305a81e70ba, replyNumber=0, likeNumber=58, createdTime=2016-11-05, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=305a81e70ba, moduleTitle=APASL 2017：第二十六届亚太肝病学会年会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=305a81e70ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519211, encodeId=653a151921184, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=2016APASL共识指南——侵入性和非侵入性评估肝纤维化发布, objectType=article, longId=79687, objectId=71f1e9687dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71f1e9687dd, replyNumber=0, likeNumber=98, createdTime=2016-10-11, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71f1e9687dd, moduleTitle=2016APASL共识指南——侵入性和非侵入性评估肝纤维化发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71f1e9687dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519210, encodeId=2169151921006, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=2016EASL建议——丙型肝炎的治疗发布, objectType=article, longId=78931, objectId=84a7e893169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84a7e893169, replyNumber=0, likeNumber=0, createdTime=2016-09-30, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84a7e893169, moduleTitle=2016EASL建议——丙型肝炎的治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84a7e893169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519209, encodeId=57861519209c8, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读, objectType=article, longId=72155, objectId=4910e2155ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4910e2155ba, replyNumber=0, likeNumber=99, createdTime=2016-07-07, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4910e2155ba, moduleTitle=近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4910e2155ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519208, encodeId=4295151920836, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=EASL年会“更佳肝炎研究亮点”国内首次发布, objectType=article, longId=71243, objectId=0614e124337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0614e124337, replyNumber=0, likeNumber=0, createdTime=2016-06-21, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0614e124337, moduleTitle=EASL年会“更佳肝炎研究亮点”国内首次发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0614e124337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519207, encodeId=d365151920e1f, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效, objectType=article, longId=70398, objectId=4835e039867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4835e039867, replyNumber=0, likeNumber=68, createdTime=2016-06-11, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4835e039867, moduleTitle=EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4835e039867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519206, encodeId=c60515192065f, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=阿斯利康抗癌药Faslodex（氟维司群）治疗HR+晚期乳腺癌疗效显著优于Arimidex（阿那曲唑）, objectType=article, longId=69402, objectId=83826940262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83826940262, replyNumber=0, likeNumber=57, createdTime=2016-05-30, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83826940262, moduleTitle=阿斯利康抗癌药Faslodex（氟维司群）治疗HR+晚期乳腺癌疗效显著优于Arimidex（阿那曲唑）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83826940262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519205, encodeId=e9bc15192058a, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD 2015：丙肝新药Daklinza治疗晚期肝纤维化3型丙肝治愈率达100%, objectType=article, longId=59142, objectId=6c435914280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c435914280, replyNumber=0, likeNumber=55, createdTime=2015-11-21, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c435914280, moduleTitle=AASLD 2015：丙肝新药Daklinza治疗晚期肝纤维化3型丙肝治愈率达100%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c435914280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519204, encodeId=5d8c151920491, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=APASL乙型肝炎指南更新版解读, objectType=article, longId=51923, objectId=3c52519231b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c52519231b, replyNumber=0, likeNumber=88, createdTime=2015-06-12, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c52519231b, moduleTitle=APASL乙型肝炎指南更新版解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c52519231b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519203, encodeId=3fe31519203da, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=EASL-ALEH 2015《无创检查评估肝脏疾病严重程度及预后临床指南》, objectType=article, longId=51330, objectId=21af51330b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21af51330b4, replyNumber=0, likeNumber=23, createdTime=2015-05-30, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21af51330b4, moduleTitle=EASL-ALEH 2015《无创检查评估肝脏疾病严重程度及预后临床指南》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21af51330b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519202, encodeId=3eff151920219, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=EASL 2015：外显子组测序有助于肝癌个体化治疗, objectType=article, longId=50157, objectId=17a85015efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17a85015efe, replyNumber=0, likeNumber=57, createdTime=2015-05-04, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17a85015efe, moduleTitle=EASL 2015：外显子组测序有助于肝癌个体化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17a85015efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519201, encodeId=2214151920170, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=APASL 2015 重要议题抢先看！, objectType=article, longId=47698, objectId=034f4e69817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=034f4e69817, replyNumber=0, likeNumber=0, createdTime=2015-03-05, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=034f4e69817, moduleTitle=APASL 2015 重要议题抢先看！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=034f4e69817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519200, encodeId=5bc0151920039, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=CSCO 2014：IASLC和CSCO间合作机会很多, objectType=article, longId=40445, objectId=a19d40445ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a19d40445ed, replyNumber=0, likeNumber=65, createdTime=2014-09-20, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a19d40445ed, moduleTitle=CSCO 2014：IASLC和CSCO间合作机会很多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a19d40445ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASL

2020-05-29

lq1771 (审核中...)

前往app查看评论内容

#ASL#

J Cereb Blood Flow Metab：大脑中动脉狭窄没有症状？ASL告诉你侧支循环灌注的差异！

2017-08-13

lq1771 (审核中...)

前往app查看评论内容

#ASL#

STROKE：玩转PET-MRI:在Moyamoya患者中，长时延迟ASL能够准确评估脑血流量

2017-08-05

lq1771 (审核中...)

前往app查看评论内容

#ASL#

J Cereb Blood Flow Metab：预测急性脑卒中缺血再灌注后出血之利器——再灌注治疗后ASL脑血流高灌注表现与出血相关

2017-07-12

lq1771 (审核中...)

前往app查看评论内容

#ASL#

EASL 2017：肝癌晚期应该怎么办？

2017-04-28

lq1771 (审核中...)

前往app查看评论内容

#ASL#

APASL分享EFFORT研究结果：替比夫定优化治疗降低耐药率至3.3%

2017-03-03

lq1771 (审核中...)

前往app查看评论内容

#ASL#

热烈祝贺“2017第26届亚太肝脏研究学会年会APASL”圆满成功！

2017-02-22

lq1771 (审核中...)

前往app查看评论内容

#ASL#

[APASL访谈]杨希忠教授：为了没有肝炎的未来

2017-02-22

lq1771 (审核中...)

前往app查看评论内容

#ASL#

APASL 2017：第二十六届亚太肝病学会年会

2016-11-05

lq1771 (审核中...)

前往app查看评论内容

#ASL#

2016APASL共识指南——侵入性和非侵入性评估肝纤维化发布

2016-10-11

lq1771 (审核中...)

前往app查看评论内容

#ASL#

2016EASL建议——丙型肝炎的治疗发布

2016-09-30

lq1771 (审核中...)

前往app查看评论内容

#ASL#

近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读

2016-07-07

lq1771 (审核中...)

前往app查看评论内容

#ASL#

EASL年会“更佳肝炎研究亮点”国内首次发布

2016-06-21

lq1771 (审核中...)

前往app查看评论内容

#ASL#

EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效

2016-06-11

lq1771 (审核中...)

前往app查看评论内容

#ASL#

阿斯利康抗癌药Faslodex（氟维司群）治疗HR+晚期乳腺癌疗效显著优于Arimidex（阿那曲唑）

2016-05-30

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD 2015：丙肝新药Daklinza治疗晚期肝纤维化3型丙肝治愈率达100%

2015-11-21

lq1771 (审核中...)

前往app查看评论内容

#ASL#

APASL乙型肝炎指南更新版解读

2015-06-12

lq1771 (审核中...)

前往app查看评论内容

#ASL#

EASL-ALEH 2015《无创检查评估肝脏疾病严重程度及预后临床指南》

2015-05-30

lq1771 (审核中...)

前往app查看评论内容

#ASL#

EASL 2015：外显子组测序有助于肝癌个体化治疗

2015-05-04

lq1771 (审核中...)

前往app查看评论内容

#ASL#

APASL 2015 重要议题抢先看！

2015-03-05

lq1771 (审核中...)

前往app查看评论内容

#ASL#

CSCO 2014：IASLC和CSCO间合作机会很多

2014-09-20

科室
- - 订阅+
  - 更多科室
工具
服务